New Zealand markets open in 1 hour 7 minutes

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
56.74-0.76 (-1.32%)
As of 03:53PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.21B
Enterprise value 1.27B
Trailing P/E 48.37
Forward P/E 9.43
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.07
Price/book (mrq)2.66
Enterprise value/revenue 2.36
Enterprise value/EBITDA 10.91

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-1.93%
S&P500 52-week change 334.08%
52-week high 370.81
52-week low 348.20
50-day moving average 360.37
200-day moving average 361.66

Share statistics

Avg vol (3-month) 3350.49k
Avg vol (10-day) 3346.59k
Shares outstanding 521.03M
Implied shares outstanding 621.03M
Float 815.91M
% held by insiders 111.15%
% held by institutions 183.76%
Shares short (13 Sept 2024) 42.22M
Short ratio (13 Sept 2024) 46.01
Short % of float (13 Sept 2024) 413.69%
Short % of shares outstanding (13 Sept 2024) 410.57%
Shares short (prior month 15 Aug 2024) 41.67M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 318 Jul 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 5.01%
Operating margin (ttm)6.54%

Management effectiveness

Return on assets (ttm)3.38%
Return on equity (ttm)5.90%

Income statement

Revenue (ttm)538.95M
Revenue per share (ttm)28.24
Quarterly revenue growth (yoy)18.40%
Gross profit (ttm)N/A
EBITDA 107.97M
Net income avi to common (ttm)22.93M
Diluted EPS (ttm)1.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)247.05M
Total cash per share (mrq)12.66
Total debt (mrq)289.92M
Total debt/equity (mrq)60.32%
Current ratio (mrq)3.97
Book value per share (mrq)23.31

Cash flow statement

Operating cash flow (ttm)112.59M
Levered free cash flow (ttm)82.53M